Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Decisions about add-on reimbursement for medical devices in France in May

02 Aug 2018

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 11 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in June.

Nine decisions were released for prosthesis:

  • Hydra (with cement), femoral stem (application for registration, approved)
  • Hydra (without cement), femoral stem (application for registration, approved)
  • Apta (with cement), femoral stem (application for registration, approved)
  • Apta (without cement), femoral stem (application for registration, approved)
  • Acuta (without cement), femoral stem (application for registration, approved)
  • Recta (without cement), femoral stem (application for registration, approved)
  • Hip’n go (without cement), acetabular cup with double mobility (application for registration, approved)
  • Hip’n go (to cement), acetabular cup with double mobility (application for registration, approved)
  • Serenity, acetabular cup with double mobility (application for registration, approved)

One decision was released for endobronchial valves:

  • Zephyr, endobronchial valves system(application for registration, approved)

One decision was released for other devices:

  • Eden, male condom (application for registration, approved)

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.